Cargando…

Minimal Effect of Bevacizumab Treatment on Residual Vestibular Schwannomas after Partial Resection in Young Neurofibromatosis Type 2 Patients

Hearing-preserving partial resection of neurofibromatosis type 2 (NF2) associated vestibular schwannomas (VS) is a preferred treatment strategy, particularly for children and adolescents. However, the residual tumors do grow and lead at some point to continued hearing deterioration. An adjuvant beva...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gugel, Isabel, Kluwe, Lan, Zipfel, Julian, Teuber, Christian, Tatagiba, Marcos, Mautner, Victor-Felix, Schuhmann, Martin Ulrich, Grimm, Florian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966588/ https://www.ncbi.nlm.nih.gov/pubmed/31769423 http://dx.doi.org/10.3390/cancers11121862

Ejemplares similares

Impact of Surgery on Long-Term Results of Hearing in Neurofibromatosis Type-2 Associated Vestibular Schwannomas
por: Gugel, Isabel, et al.
Publicado: (2019)

Age at Onset and Presenting Symptoms of Neurofibromatosis Type 2 as Prognostic Factors for Clinical Course of Vestibular Schwannomas
por: Gugel, Isabel, et al.
Publicado: (2020)

Presenting symptoms in children with neurofibromatosis type 2
por: Gugel, Isabel, et al.
Publicado: (2020)

Managing NF2-associated vestibular schwannomas in children and young adults: review of an institutional series regarding effects of surgery and bevacizumab on growth rates, tumor volume, and hearing quality
por: Gugel, Isabel, et al.
Publicado: (2020)

Management of neurofibromatosis type 2 and schwannomatosis associated peripheral and intraspinal schwannomas: influence of surgery, genetics, and localization
por: Gugel, Isabel, et al.
Publicado: (2022)

Risk Stratification for Immediate Postoperative Hearing Loss by Preoperative BAER (Brainstem Auditory Evoked Response) and Audiometry in NF2-Associated Vestibular Schwannomas
por: Gugel, Isabel, et al.
Publicado: (2021)

Management of Sporadic Vestibular Schwannomas in Children—Volumetric Analysis and Clinical Outcome Assessment
por: Zipfel, Julian, et al.
Publicado: (2022)

Cerebrovascular Insult as Presenting Symptom of Neurofibromatosis Type 2 in Children, Adolescents, and Young Adults
por: Gugel, Isabel, et al.
Publicado: (2018)

Bevacizumab Therapy of Neurofibromatosis Type 2 Associated Vestibular Schwannoma in Japanese Patients
por: FUJII, Masazumi, et al.
Publicado: (2020)

Occurrence and management of postoperative pneumocephalus using the semi-sitting position in vestibular schwannoma surgery
por: Machetanz, Kathrin, et al.
Publicado: (2020)

Surgical Management of Sporadic Peripheral Nerve Schwannomas in Adults: Indications and Outcome in a Single Center Cohort
por: Zipfel, Julian, et al.
Publicado: (2021)

Sex Differences in Vestibular Schwannoma
por: Machetanz, Kathrin, et al.
Publicado: (2023)

Withdrawal of bevacizumab is associated with rebound growth of vestibular schwannomas in neurofibromatosis type 2-related schwannomatosis patients
por: Webb, M J, et al.
Publicado: (2023)

Association of extent of resection on recurrence-free survival and functional outcome in vestibular schwannoma of the elderly
por: Wang, Sophie Shih-Yüng, et al.
Publicado: (2023)

Contribution of mTOR and PTEN to Radioresistance in Sporadic and NF2-Associated Vestibular Schwannomas: A Microarray and Pathway Analysis
por: Gugel, Isabel, et al.
Publicado: (2020)

New developments in neurofibromatosis type 2 and vestibular schwannoma
por: Ren, Yin, et al.
Publicado: (2020)

Quality of Life After Vestibular Schwannoma Surgery: A Question of Perspective
por: Bender, Miriam, et al.
Publicado: (2022)

Role, function and challenges of multidisciplinary centres for rare diseases exemplified for neurofibromatosis type 1 syndrome
por: Toledano-Alhadef, Hagit, et al.
Publicado: (2020)

The behavior of residual tumors following incomplete surgical resection for vestibular schwannomas
por: Park, Hun Ho, et al.
Publicado: (2021)

Retrosigmoid Transmeatal Endoscope-Assisted Approach in Semi-Sitting Position for Resection of Vestibular Schwannoma: 2-D operative Video
por: Evangelista-Zamora, Rocio, et al.
Publicado: (2018)

Trading mental and physical health in vestibular schwannoma treatment decision
por: Machetanz, Kathrin, et al.
Publicado: (2023)

Herpes simplex meningitis after vestibular schwannoma surgery: illustrative case
por: Trakolis, Leonidas, et al.
Publicado: (2021)

MRI based volumetric measurements of vestibular schwannomas in patients with neurofibromatosis type 2: comparison of three different software tools
por: Kollmann, Philipp, et al.
Publicado: (2020)

Low-dose bevacizumab induces radiographic regression of vestibular schwannomas in neurofibromatosis type 2: A case report and literature review
por: LIU, PENGFEI, et al.
Publicado: (2016)

Correction to: Surgical management of peripheral nerve sheath tumours in children, with special consideration of neurofibromatoses
por: Zipfel, Julian, et al.
Publicado: (2021)

Surgical management of peripheral nerve sheath tumours in children, with special consideration of neurofibromatoses
por: Zipfel, Julian, et al.
Publicado: (2020)

Multiple synchronous sites of origin of vestibular schwannomas in neurofibromatosis Type 2
por: Stivaros, Stavros M, et al.
Publicado: (2015)

A Bilateral Vestibular Schwannoma is Not Always Related to Neurofibromatosis Type 2
por: Abeshi, Andi, et al.
Publicado: (2023)

COX2 expression is associated with proliferation and tumor extension in vestibular schwannoma but is not influenced by acetylsalicylic acid intake
por: Behling, Felix, et al.
Publicado: (2019)

Predictors of Preoperative Tinnitus in Unilateral Sporadic Vestibular Schwannoma
por: Naros, Georgios, et al.
Publicado: (2017)

Translabyrinthine Approach for Resection of Vestibular Schwannoma
por: Feng, Yening, et al.
Publicado: (2019)

Management of Bevacizumab-Induced Proteinuria Using an Angiotensin Receptor Blocker (ARB) in a Neurofibromatosis Type 2 (NF-2) Patient With Vestibular Schwannoma
por: Omene, Egiroh E, et al.
Publicado: (2023)

The impact of stereotactic radiosurgery in the management of neurofibromatosis type 2-related vestibular schwannomas
por: Lustgarten, Leonardo
Publicado: (2013)

Neurofibromatosis Type 2 (NF2) and the Implications for Vestibular Schwannoma and Meningioma Pathogenesis
por: Bachir, Suha, et al.
Publicado: (2021)

Long-Term Outcomes of Stereotactic Radiosurgery for Vestibular Schwannoma Associated with Neurofibromatosis Type 2 in Comparison to Sporadic Schwannoma
por: Shinya, Yuki, et al.
Publicado: (2019)

Ipsilateral Vestibular Schwannoma after Cochlear Implantation
por: Tüpker, S., et al.
Publicado: (2022)

Partial Hearing Preservation after Translabyrinthine Vestibular Schwannoma Resection: Case Report and Review of the Literature
por: Ahsan, Syed F., et al.
Publicado: (2015)

Vestibular schwannoma associated with neurofibromatosis type 2: Clinical course following stereotactic radiosurgery
por: Kim, Junhyung, et al.
Publicado: (2022)

Repetitive Transcranial Magnetic Stimulation for Tinnitus Treatment in Vestibular Schwannoma: A Pilot Study
por: Leao, Maria Teresa, et al.
Publicado: (2021)

Rationale and Design of BeatNF2 Trial: A Clinical Trial to Assess the Efficacy and Safety of Bevacizumab in Patients with Neurofibromatosis Type 2 Related Vestibular Schwannoma
por: Fujii, Masazumi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k38jof8lngp0f70j1s6i6d1ab2